RecruitingNCT00556530

Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

Genetic Modifiers of 22q11.2 Deletion Syndrome

Sponsor

Albert Einstein College of Medicine

Enrollment

1,000 participants

Start Date

Jul 1, 2016

Study Type

OBSERVATIONAL

Conditions

22q11.2 Deletion Syndrome DiGeorge Syndrome

Summary

22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with 22q11.2 deletion syndrome and digeorge syndrome. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.